Minten, T., Adelson, S., Amendola, L., Bick, D., Boemer, F., Coffey, A., Encina, N., Russell, B., Servais, L., Sund, K., Taft, R., Green, R., & Gold, N. (2024). P213: Exploring heterogeneity among gene lists proposed for newborn sequencing. Genetics in Medicine Open, 2, 101110. doi:10.1016/j.gimo.2024.101110 Peer reviewed |
Dangouloff, T., Thokala, P., Stevenson, M. D., Deconinck, N., D'Amico, A., Daron, A., DELSTANCHE, S., Servais, L., & Hiligsmann, M. (02 December 2023). Cost-effectiveness of spinal muscular atrophy newborn screening based on real-world data in Belgium. Neuromuscular Disorders, 34, 61-67. doi:10.1016/j.nmd.2023.11.013 Editorial reviewed |
Poleur, M., Tricot, A., Medard, L., Gevenois, N., Lozeve, D., Maertens De Noordhout, A., Bouquiaux, O., Lommers, E., Michaud, M., Annoussamy, M., & Servais, L. (2023). Analytical validation of innovative magneto-inertial outcomes: a controlled environment study. Multiple Sclerosis Journal. Peer Reviewed verified by ORBi |
Servais, L., Eggenspieler, D., Poleur, M., Grelet, M., Muntoni, F., Strijbos, P., & Annoussamy, M. (October 2023). First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD. Nature Medicine, 29 (10), 2391 - 2392. doi:10.1038/s41591-023-02459-5 Peer Reviewed verified by ORBi |
Hustinx, M., Poleur, M., Daron, A., Maertens De Noordhout, A., Servais, L., & Delstanche, S. (2022). Overlap Between Hereditary Sensory- Motor Neuropathy (HSMN) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). Journal of Neuromuscular Diseases. Peer Reviewed verified by ORBi |
Poleur, M., Annoussamy, M., Clavel, L., Buscemi, L., DELSTANCHE, S., Eggenspieler, D., Maertens De Noordhout, A., Bouquiaux, O., Lievens, I., & Servais, L. (2022). Wearable inertial sensors for longitudinal follow-up of patients with amyotrophic lateral sclerosis. Nervno-Myšečnye Bolezni. Peer Reviewed verified by ORBi |
Annoussamy, M., Eggenspieler, D., Seferian, A., Mercuri, E., Straub, V., Muntoni, F., Scoto, M., Poleur, M., Daron, A., Butoianu, N., Mirea, A., Goemans, N., Previtali, S., Tulinius, M., Nascimento, A., Heydemann, P., Panzara, M., Singh, T., Strijbos, P., & Servais, L. (2022). Application for primary endpoint qualification of the 95th centile of stride velocity (SV95C) in Duchenne muscular dystrophy. Neuromuscular Disorders. doi:10.1016/j.nmd.2022.07.099 Peer Reviewed verified by ORBi |